Acetylenic .beta.-sulfonamido and phosphinic acid amide hydroxamic acid TACE inhibitors
US6326516A · kind A · utility
14Cited by
10References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 27, 2000 |
| Grant date | Dec 4, 2001 |
| Priority date | — |
| Expiry date | Jan 27, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2602/42
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention discloses hydroxamide acids of the formula: ##STR1## which are useful in treating disease conditions mediated by TNF-.alpha., such as rheumatoid arthritis, osteoarthritis, sepsis, AIDS, ulcerative colitis, multiple sclerosis, Crohn's disease and degenerative cartilage loss.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.